Olema Pharmaceuticals Inc

Research Olema Pharmaceuticals Inc (OLMA) on Bullrun: market cap USD 1.07B. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerOLMA
• ExchangeNASDAQ
• CountryUnited States
• SectorHealthcare
• IndustryBiotechnology
• CurrencyUSD
• Market capUSD 1.07B
• Financial periodFY2025
• Net income-USD 162.45M

Valuation Snapshot

latest market cap is USD 1.07B.

About Olema Pharmaceuticals Inc

Olema Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies for women's cancers. The company's lead product candidate is palazestrant, an estrogen receptor (ER) antagonist and a selective ER degrader, which is in Phase 3 clinical trial for the treatment of recurrent, locally advanced, or metastatic ER-positive, human epidermal growth factor receptor 2-negative breast cancer;

Frequently asked questions

What is Olema Pharmaceuticals Inc's market cap?

Olema Pharmaceuticals Inc's market capitalization is USD 1.07B.

What does Olema Pharmaceuticals Inc do?

Olema Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies for women's cancers.